BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Luo WF, Jiao YT, Lin XL, Zhao Y, Wang SB, Shen J, Deng J, Ye YF, Han ZP, Xie FM, He JH, Wan Y. Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population. World J Gastrointest Oncol 2024; 16(4): 1361-1373 [PMID: 38660655 DOI: 10.4251/wjgo.v16.i4.1361]
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1361.htm
Number Citing Articles
1
Timothy J. O'Leary. Colorectal Cancer ScreeningThe Journal of Molecular Diagnostics 2024; 26(8): 669 doi: 10.1016/j.jmoldx.2024.05.003
2
Hyoung Il Choi, Jae Myung Cha, Young Sang Kim, Dae Hyeon Cho, Han Ju Pack, Soo-Young Na, Ji Hye Kim, Hyun Gun Kim, Young-Jin Park, Hye Jung Kwon, Kyeong Ok Kim, Geon Ho Lee, Yoo Jin Lee. Stool DNA-based SDC2 Methylation Test for the Screening of Colorectal Neoplasia in an Asymptomatic, Average-Risk PopulationThe Korean Journal of Gastroenterology 2026; 86(1): 43 doi: 10.4166/kjg.2025.129
3
Zhenhai Jing. Meta-analysis on the diagnostic value of Syndecan 2 methylation in stool for the detection of colorectal cancerAmerican Journal of Translational Research 2025; 17(6): 4421 doi: 10.62347/LBQG7510